China approves clinical trials of Sinopharm's Omicron-specific vaccine

CMAC Pauses Demining Activities in Eight Provinces as US Foreign Aid Freeze * Chinese President Thanks Samdech Techo Hun Sen for Condolences over Earthquake Tragedy in Xizang Autonomous Region * US Senate democrats block ICC sanctions bill over Netanyahu warrant * EU members of NATO ready to raise defence spending beyond 2% of GDP, Costa says

: Created: 26 April 2022; Hits: 2444

BEIJING, April 26 (CGTN) - China's National Medical Products Administration on Tuesday approved Sinopharm's COVID-19 vaccine specified for Omicron variant for clinical trials.